icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
n42ngxMYfUx37NMC
Listen
